HomeTagsHealth

health

SGX-LISTED COMPANIES

ISEC Healthcare Q3 FY2026 Revenue Grows Amid Expansion Cost Pressures

Revenue Growth Amid Profit Compression ISEC Healthcare’s Q3 FY2026 results reveal a clear operational split....
SGX-LISTED COMPANIES

Mary Chia Releases Q1 FY2027 Amid Corporate Restructuring

Financial Statements Amid Structural Transition Mary Chia Holdings Limited has officially released its condensed interim...
SGX-LISTED COMPANIES

Why ISEC Healthcare’s Q1 2026 Profit Dip Isn’t What It Seems

In the world of financial reporting, a double-digit drop in net profit is usually...
SGX-LISTED COMPANIES

How Vietnam Is Negatively Impacting Hyphens Pharma’s Growth

The Southeast Asian Pharmaceutical Puzzle Navigating the healthcare landscape in Southeast Asia is often described...
SGX-LISTED COMPANIES

Tianjin Pharmaceutical Da Ren Tang Is Shrinking To Succeed In FY2025

How TJ DRT’s 33% Revenue "Loss" Fueled a 72% Margin Miracle and a Record...
SGX-LISTED COMPANIES

The Strategy Keeping Camsing Healthcare Alive – FY2026

The Survival Pivot: 4 Lessons from a Retail Healthcare Turnaround Introduction: The narrative of the legacy...
SGX-LISTED COMPANIES

Why China Medical Systems FY2025 Profits Dropped Despite Growth

https://open.spotify.com/episode/3YAldvdzS4eXE4RzkN9M18?si=8a54594510534cfe 5 Game-Changing Takeaways from CMS’s 2025 Transformation For the Chinese pharmaceutical sector, 2025 was the...
SGX-LISTED COMPANIES

How Raffles Medical Is Trading Episodic Care For Longevity Science In FY2025

Introduction: A Half-Century of Evolution As Raffles Medical Group (RMG) marks its 50th anniversary, it...
SGX-LISTED COMPANIES

iX Biopharma’s Secret Shortcut To The US Medical Market – 1H FY2026

From Cash Burn to Bioavailability: How iX Biopharma Slashed Losses by 67% via a...
SGX-LISTED COMPANIES

From Superfoods To Senior Care – Autagco Q1 FY2026

The High-Stakes Gamble of a Singapore Mainstay Introduction: The "Pivot or Perish" Reality In the unforgiving...
SGX-LISTED COMPANIES

Is Camsing Healthcare In Survival Mode? The Truth Behind Their Q3 FY2026

On the Brink of Collapse: 3 Surprising Truths Buried in Camsing Healthcare's Latest Report 1....
SGX-LISTED COMPANIES

One Asset Deal Changed Everything For Tianjin Da Ren Tang In Q3 2025

How Tianjin Da Ren Tang's Revenue Fell 35% While Its Profits Soared: 4 Surprising...
Load more
spot_img

Latest articles

SGX-LISTED COMPANIES

Metasurface Technologies Expands Regional Footprint With SGX Catalist Listing

Listing Overview Precision component engineering provider Metasurface Technologies Holdings Limited is expanding its capital markets...
SGX-LISTED COMPANIES

Lion Asiapac Stays Profitable In Q1 2026 But Core Segment Challenges Lurk Beneath Surface

Lion Asiapac Q1 2026 Results Reveal Hidden Strengths and Clear Red Flags for Investors Investors...
SGX-LISTED COMPANIES

Miyoshi Limited Cuts FY2026 Net Losses By Half But Liquidity Risks Loom Large

Shrinking Losses Amid Operational Shift and Liquidity Hurdles Miyoshi Limited has officially released its full-year...
AI

NusaVest targets US$2B ABSs to ease digital economy funding squeeze

NusaVest is aiming to facilitate at least US$2 billion in asset-backed securities transactions over...